Cardiovascular disease prevention

were commissioned to ensure there was ample geographical coverage. The main issues arising from these studies are set out in appendix C under fieldwork findings. See the full fieldwork report on prevention of cardiovascular disease at population level. How the PDG formulated the recommendations At its meetings between September 2008 and July 2009, the PDG considered the evidence of effectiveness, expert reports and cost effectiveness to determine: • whether there was sufficient evidence (in terms of strength and applicability) to form a judgement • where relevant, whether (on balance) the evidence demonstrates that the intervention or programme/activity can be effective or is inconclusive • where relevant, the typical size of effect (where there is one) • Whether the evidence is applicable to the target groups and context covered by the guidance. The PDG developed draft recommendations through informal consensus, based on the following criteria: • Strength (type, quality quantity and consistency) of the evidence. • The applicability of the evidence to the populations/settings referred to in the scope. • Effect size and potential impact on the target population's health. • Impact on inequalities in health between different groups of the population. • Equality and diversity legislation. • Ethical issues and
